M. Gianni'

Retinoic Acid Induces Proteasome-Dependent Degradation of Retinoic Acid Receptor α (RARα) and Oncogenic RARα Fusion Proteins

M. Koken, E. Kopf, C. Rochette-Egly, 1999 .

AM 580 , a Stable Benzoic Derivative of Retinoic Acid , Has Powerful and Selective Cyto-Differentiating Effects on Acute Promyelocytic Leukemia Cells

M. Calzi, T. Barbui, S. Caccia, 2002 .

AM580, a stable benzoic derivative of retinoic acid, has powerful and selective cyto-differentiating effects on acute promyelocytic leukemia cells.

T. Barbui, S. Caccia, A. Rambaldi, 1996, Blood.

Inhibition of melanogenesis by BMY-28565, a novel compound depressing tyrosinase activity in B16 melanoma cells.

L. Tabe, E. Garattini, M. Gianni', 1992, Biochemical pharmacology.

The Novel Synthetic Retinoid 6-(3-adamantyl-4-hydroxyphenyl)-2-naphthalene Carboxylic Acid (CD437) Causes Apoptosis in Acute Promyelocytic Leukemia Cells Through Rapid Activation of Caspases

U. Reichert, D. Bergamaschi, A. Rambaldi, 1999 .

Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases

U. Reichert, A. Rambaldi, E. Garattini, 2000, Cell Death and Differentiation.

Bis-indols: a novel class of molecules enhancing the cytodifferentiating properties of retinoids in myeloid leukemia cells.

C. Pisano, F. F. Ferrara, L. Vesci, 2002, Blood.

Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARα fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient

J. Licht, A. Zelent, M. Koken, 1999, Oncogene.

Network-guided modeling allows tumor-type independent prediction of sensitivity to all-trans-retinoic acid

S. Garattini, T. Castrignanò, L. Pattini, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid

L. Goracci, G. Cruciani, M. Lupi, 2019, Journal of Experimental & Clinical Cancer Research.

Antitumor Activity of the Retinoid-Related Molecules (E)-3-(4′-Hydroxy-3′-adamantylbiphenyl-4-yl)acrylic Acid (ST1926) and 6-[3-(1-Adamantyl)-4-hydroxyphenyl]-2-naphthalene Carboxylic Acid (CD437) in F9 Teratocarcinoma: Role of Retinoic Acid Receptor γ and Retinoid-Independent Pathways

I. Raška, S. Dallavalle, L. Diomede, 2006, Molecular Pharmacology.